Efficacy of repeat-dose rituximab maintenance therapy for minimal change disease in adults

ConclusionsRepeat-dose RTX as maintenance therapy efficiently prevented recurrence and was well tolerated in adult MCD patients including older. This regimen has the potential to maintain prolonged remission. Future studies in larger cohorts are needed to identify the optimal dose and frequency and evaluate the long-term effectiveness and safety of this regimen.
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research